BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7529855)

  • 1. DNA ploidy in prostate cancer: potential measurement as a surrogate endpoint biomarker.
    Lieber MM
    J Cell Biochem Suppl; 1994; 19():246-8. PubMed ID: 7529855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.
    Visakorpi T; Hyytinen E; Kallioniemi A; Isola J; Kallioniemi OP
    Am J Pathol; 1994 Sep; 145(3):624-30. PubMed ID: 8080044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies.
    Takahashi S; Qian J; Brown JA; Alcaraz A; Bostwick DG; Lieber MM; Jenkins RB
    Cancer Res; 1994 Jul; 54(13):3574-9. PubMed ID: 8012984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic intraepithelial neoplasia (PIN) and other prostatic lesions as risk factors and surrogate endpoints for cancer chemoprevention trials.
    Bostwick DG; Aquilina JW
    J Cell Biochem Suppl; 1996; 25():156-64. PubMed ID: 9027613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma.
    Takahashi S; Alcaraz A; Brown JA; Borell TJ; Herath JF; Bergstralh EJ; Lieber MM; Jenkins RB
    Clin Cancer Res; 1996 Jan; 2(1):137-45. PubMed ID: 9816100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer.
    Alcaraz A; Barranco MA; Corral JM; Ribal MJ; Carrió A; Mallofré C; Llopis J; Cetina A; Alvarez-Vijande R
    Prostate; 2001 Apr; 47(1):29-35. PubMed ID: 11304727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific DNA probes.
    Zitzelsberger H; Szücs S; Weier HU; Lehmann L; Braselmann H; Enders S; Schilling A; Breul J; Höfler H; Bauchinger M
    J Pathol; 1994 Apr; 172(4):325-35. PubMed ID: 8207613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.
    Huang SF; Xiao S; Renshaw AA; Loughlin KR; Hudson TJ; Fletcher JA
    Am J Pathol; 1996 Nov; 149(5):1565-73. PubMed ID: 8909246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray.
    Skacel M; Ormsby AH; Pettay JD; Tsiftsakis EK; Liou LS; Klein EA; Levin HS; Zippe CD; Tubbs RR
    Hum Pathol; 2001 Dec; 32(12):1392-7. PubMed ID: 11774175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials.
    Bostwick DG; Burke HB; Wheeler TM; Chung LW; Bookstein R; Pretlow TG; Nagle RB; Montironi R; Lieber MM; Veltri RW
    J Cell Biochem Suppl; 1994; 19():283-9. PubMed ID: 7529857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
    Qian J; Jenkins RB; Bostwick DG
    Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Numerical aberrations of chromosomes 8, 9, 11, and 17 in squamous cell carcinoma of the pharynx and larynx: a fluorescence in situ hybridization and DNA flow cytometric analysis of 50 cases.
    Hardisson D; Alvarez-Marcos C; Salas-Bustamante A; Alonso-Guervós M; Sastre N; Sampedro A
    Oral Oncol; 2004 Apr; 40(4):409-17. PubMed ID: 14969820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
    Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostate cancers and potential precancerous conditions: DNA cytometric investigations and interphase cytogenetics].
    Baretton G; Vogt T; Valina C; Schneiderbanger K; Löhrs U
    Verh Dtsch Ges Pathol; 1993; 77():86-92. PubMed ID: 7511309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer.
    Macoska JA; Trybus TM; Sakr WA; Wolf MC; Benson PD; Powell IJ; Pontes JE
    Cancer Res; 1994 Jul; 54(14):3824-30. PubMed ID: 8033102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB; Qian J; Lieber MM; Bostwick DG
    Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of chromosomal trisomies in prostate cancer using fluorescent in situ hybridization.
    Mark HF; Feldman D; Das S; Samy M; Sun CL; Mark S
    Exp Mol Pathol; 1999 Oct; 67(2):109-17. PubMed ID: 10527762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection toward diploid cells in prostatic carcinoma derived cell cultures.
    Ketter R; Zwergel T; Romanakis K; Unteregger G; Ziegler M; Zang KD; Wullich B
    Prostate; 1996 Jun; 28(6):364-71. PubMed ID: 8650073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
    Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
    Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.